Skip to main content

Antares Pharma, Inc.

ATRSDelisted May 24, 2022
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001016169

Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.

Q4 2022 vs. Q3 2022

How the institutions holding Antares Pharma, Inc. changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of ATRS: Q3 2022 compared with Q4 2022
MeasureQ3 2022Q4 2022Change
Holders10−1
Shares4.37K0−4.37K (−100.0%)
Value$12.0K$0−$12.0K (−100.0%)

New holders (0)

Institutions that held Antares Pharma, Inc. at the end of Q4 2022 but not at the end of Q3 2022.

None.

Sold out (1)

Institutions that held Antares Pharma, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.

Institutions that sold out of ATRS in Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
IFP Advisors, Inc4,369$12.0K